Folder View

Please be advised that not all documents in our library meet WCAG 2.1AA Accessibility Requirements.



Guidance on how to use bisphosphonates and other bone modifying drugs in haematology and oncology patients.Key words:Oncology, Haematology, Myeloma, Bone, Bisphosphonates, Denosumab
Valid To: 08/04/2023
Publication Type: Guidelines
General overview of CINV including guidance on the prescribing of antiemetic's for CINV
Valid To: 07/06/2022
Publication Type: Guidelines
How to assess and manage suspected Cancer Associated Thrombosis in patients receiving chemotherapy including what education should be provided to patients.
Valid To: 19/02/2023
Publication Type: Guidelines
How to assess and manage Systemic Anti-Cancer therapy induced Diarrhoea, patient education and management.
Valid To: 04/06/2022
Publication Type: Guidelines
Updated SOP for Bone Marrow Aspiration and Trephine biopsy
Valid To: 26/11/2023
Publication Type: Procedures
To authorise appropriately qualified non-medical practitioners to request specified X-ray examinations, adhering to the ionising radiation Regulations IR(ME)R and the Royal College of radiologists guidelines
Valid To: 21/02/2022
Publication Type: Guidelines
This guideline applies to patients presenting to RCHT with potential side effects from immunotherapy treatment for cancer. It defines the optimal management.
Valid To: 25/11/2022
Publication Type: Guidelines
How to assess and manage patients with suspected malignant spinal cord compression
Valid To: 30/08/2022
Publication Type: Guidelines
This guideline applies to patients presenting to RCHT with potential bowel obstruction as a consequence of cancer. It defines the agreed optimal management.
Valid To: 27/01/2024
Publication Type: Guidelines
This guideline applies to patients presenting to RCHT with potential new intracranial malignancy. This means patients with new primary brain tumours and patients with involvement of the central nervous system by extracranial malignancy (metastatic or secondary deposits). The guideline defines the optimal management within the Trust.
Valid To: 05/06/2023
Publication Type: Guidelines
This guideline applies to patients presenting to RCHT with hypercalcaemia (high serum calcium) secondary to malignancy. It defines the optimal management.
Valid To: 30/08/2022
Publication Type: Guidelines
The outline for the management of the requirement for the 24 Hour Advice Line Telephone for patients receiving SACT.The procedure for management of the 24 Hour Advice Line Telephone for patients receiving SACT
Valid To: 26/02/2022
Publication Type: Policies
This guideline applies to patients presenting to RCHT with suspected neutropenic sepsis in the setting of their treatment for non-haematological malignancy. The guideline defines the optimal acute management within the Trust and gives guidance for safe ongoing care, including managed discharge.
Valid To: 17/09/2023
Publication Type: Guidelines
How to assess and manage patients with evidence of metastatic disease where the primary source is not obvious.
Valid To: 05/02/2024
Publication Type: Guidelines
Policy for the use of the mobile cancer care unit in Cornwall
Valid To: 18/12/2022
Publication Type: Policies
SOP covering management of patients receiving hydroxycarbamide via a nurse led telephone clinic.
Valid To: 13/08/2023
Publication Type: Procedures
Procedure for nurse led local anaesthetic transperineal prostate biopsies, including competence criteria/assessment.
Valid To: 28/09/2023
Publication Type: Procedures
This document outlines guidelines for the prevention and management of extravasation and the rapid treatment of SACT injuries. It provides a guideline to assist practitioners in the care of patients who may have experienced a SACT extravasation injury.
Valid To: 14/03/2022
Publication Type: Guidelines
Guidance and education on the prevention and management of oral complications in patients receiving SACT.
Valid To: 04/06/2022
Publication Type: Guidelines
Guidelines for the use and care of scalp cooling equipment
Valid To: 04/06/2022
Publication Type: Guidelines
Defines the policy for the identification, education, assessment and supply of subcutaneous SACT for patients receiving subcutaneous treatment for cancer
Valid To: 09/10/2023
Publication Type: Policies
Recommendations for the prescribing and administration of mesna with ifosfamide and cyclophosphamide for adult cancer patients.
Valid To: 14/11/2022
Publication Type: Guidelines
Defines the local guideline for safe administration of intrathecal chemotherapy, in accordance with national guidelines.
Valid To: 30/12/2022
Publication Type: Guidelines
Defines the policy for safe handling and administration of cytotoxic SACT for the treatment of cancer.
Valid To: 21/11/2022
Publication Type: Policies
Nurse Led telephone clinic for men on enzalutamide or abiraterone
Valid To: 13/08/2023
Publication Type: Procedures
Guidelines on when it is appropriate to use GSCF in haematology and oncology patients undergoing chemotherapy or stem cell harvest.
Valid To: 04/06/2022
Publication Type: Guidelines

Google Translate

Text Size

Change font

Contrast